On June 17, 2021, Discover Growth Fund, LLC entered into an agreement with OWC Pharmaceutical Research Corp provides that the Company shall not affect the conversion of any of the preferred shares to the extent that after giving effect to such conversion, Discover Growth and all other attribution parties would beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after giving effect to such conversion, which provision may be may be increased up to but not in excess of 9.99% by written notice to the Issuer, which notice shall be effective 61 calendar days after the date of such notice. Discover Growth stated now it intends to resume its status as a passive investor.